Alfasigma worldwide Portugal Romania Russia Slovak Republic Spain Switzerland Tunisia Usa Therapeutic Areas / Gastroenterology Focus on Gastroenterology Through constant work alongside medical specialists and patient associations, we strive to improve the lives of those suffering from often disabling gastro-intestinal disorders, with prescription and over-the-counter drugs. We are committed to providing better therapeutic solutions for the treatment of gastrointestinal diseases where gut microbiota alteration plays an essential role, such as functional disorders (e.g. IBS) and bacterial gastroenteritis, but also hepatic encephalopathy, chronic liver disease (cirrhosis) and gastro-oesophageal reflux, all the way to offering bowel preparations for a successful colonscopy. 11% of the population is affected by IBS, women are affected more commonly than men Alfasigma S.p.A. | VAT 03432221202 | Privacy Policy | Data Subjects Rights | Cookie Policy | Legal Notice | Privacy Notices Copyright notice - ©️ 2020 Alfasigma Group The contents of this and other pages (including text, image, graphic, and animation files) and the design of the pages are protected by copyright of Alfasigma Group. Commercial use (e.g., distribution, processing, or reproduction on other internet pages) is only allowed if we have given prior written permission. Our website uses cookies in order to provide a better website usability, including “third party analytical cookies” (with reduced identification power) and profiling cookies to show you contents in line with your web browsing preferences. If you want to get further information please go to our “Cookie Policy” disclaimer. In order to set up and/or deactivate your preferences go to “Cookies Settings”. By clicking on “Accept All cookies”, you will accept the storage of all cookies on your device. By clicking on “X” you will continue to navigate the website in absence of cookies or tracking tools other than technical ones. Cookie Policy Cookies Settings Accept All Cookies